PMID: 7026794Mar 1, 1981Paper

Effectiveness of relaxation training in reducing adverse reactions to cancer chemotherapy

Journal of Behavioral Medicine
T G Burish, J N Lyles

Abstract

Cancer patients who had developed negative conditioned responses to their chemotherapy either did (relaxation training) or did not (no relaxation training) receive progressive muscle relaxation training and guided relaxation imagery instructions immediately before and during their chemotherapy treatments. Physiological (blood pressure and pulse rate) measures of arousal, frequency of vomiting, and patient-reported and nurse-reported indices of negative affect and nausea were collected during pretraining, training and posttraining chemotherapy sessions. Results indicated that during both the training and the posttraining sessions, patients in the relaxation training condition reported feeling less emotionally distressed and nauseated, and showed less physiological arousal following the chemotherapy infusion, than patients in the no relaxation training condition. The attending nurses' observations confirmed the patients' self-reports. No differences were found in frequency of vomiting between conditions. These data clearly suggest that the use of relaxation procedures may be an effective means of reducing several of the adverse side effects of cancer chemotherapy.

References

Mar 1, 1979·Journal of Human Stress·A D Weisman, H J Sobel
Mar 1, 1977·Archives of General Psychiatry·C B TaylorS Agras
Dec 1, 1979·Journal of Consulting and Clinical Psychology·H Abikoff, P P Ramsey
Mar 1, 1978·Biofeedback and Self-regulation·R A Kinsman, H Staudenmayer
Jul 1, 1977·The Medical Clinics of North America·J Holland
Jan 1, 1975·Nursing Forum·S Golden
Apr 1, 1975·The American Journal of Clinical Hypnosis·W LaBawD Eccles
Jan 1, 1976·The International Journal of Clinical and Experimental Hypnosis·C R DempsterB T Whalen
Nov 1, 1970·Behaviour Research and Therapy·M H Lader, A M Mathews
Nov 30, 1956·Annals of the New York Academy of Sciences·J I LACEY
Oct 1, 1964·Journal of Consulting Psychology·M ZUCKERMANE VALERIUS

❮ Previous
Next ❯

Citations

May 1, 1992·Journal of Clinical Psychology·T W DeckerM Gallagher
Aug 13, 2005·Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer·Lis AdamsenMikael Rorth
Apr 21, 2006·Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer·Rick W WilsonPaul B Jacobsen
Sep 1, 1982·Journal of Behavior Therapy and Experimental Psychiatry·L K Hamberger
May 15, 1998·Seminars in Oncology Nursing·J V Pasacreta, M Pickett
Feb 16, 2000·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·J Blake-MortimerD Spiegel
Dec 9, 1982·The New England Journal of Medicine·G R Morrow, C Morrell
Oct 1, 1982·The American Journal of Clinical Hypnosis·W H ReddC S Hendler
Jul 1, 1984·The American Journal of Clinical Hypnosis·J M Kaye
Mar 8, 2005·The Journal of Alternative and Complementary Medicine : Research on Paradigm, Practice, and Policy·Larry W ScherwitzRebecca Herrero
Jun 8, 2001·Journal of the National Cancer Institute·W H ReddK N DuHamel
Nov 3, 1996·Quality in Health Care : QHC·A MelvilleT Sheldon
Oct 7, 2011·The Primary Care Companion to CNS Disorders·Carmen L WatkinsTheodore A Stern
Jun 1, 1982·Psychosomatics·E R Katz
Jan 1, 1991·Chest·J Bernhard, P A Ganz
Mar 1, 1983·Psychosomatics·M A AndrykowskiA K Hatfield
May 1, 1985·Seminars in Oncology Nursing·L Bayuk
Jun 7, 2015·Clinical Oncology : a Journal of the Royal College of Radiologists·D R FenlonM S Hunter
Jun 1, 1984·Journal of Behavior Therapy and Experimental Psychiatry·T A AhlesT M Keane
Sep 1, 1984·Cancer Treatment Reviews·D MoherJ L Pater
Nov 1, 1985·Preventive Medicine·B RimerB Glassman
Nov 1, 1990·General Hospital Psychiatry·J M Kaye, B A Schindler
Jan 1, 1986·Image--the Journal of Nursing Scholarship·D E Mast
Jun 1, 1995·Complementary Therapies in Nursing & Midwifery·C Stevensen
Jun 13, 2006·Complementary Therapies in Medicine·William E LaffertyDonald L Patrick
Nov 1, 1985·Seminars in Oncology Nursing·P W Klein
Nov 7, 2016·Journal of Immigrant and Minority Health·Claudia X Aguado LoiViki Huegel
Mar 14, 2012·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Lara TraegerWilliam F Pirl
Mar 14, 2012·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Madeline LiGary Rodin
Jun 18, 2002·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Paul B JacobsenJohn C Ruckdeschel

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.